Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications

• Published in: Nano convergence 2022-04, Vol.9 (1), p.19-31, Article 19
• Main Authors: Chuang, Skylar T., Conklin, Brandon, Stein, Joshua B., Pan, George, Lee, Ki-Bum
• Format: Article
• Language: English
• Subjects: Cancer; CAR T-cell therapy; Chemistry and Materials Science; Immunotherapy; Materials Science; Nano-immunoengineering; Nanoparticles; Nanoscale Science and Technology; Nanotechnology; Nanotechnology and Microengineering; Review; Vaccines
• ISSN: 2196-5404; 2196-5404
• DOI: 10.1186/s40580-022-00310-0

Immunotherapy has reached clinical success in the last decade, with the emergence of new and effective treatments such as checkpoint blockade therapy and CAR T-cell therapy that have drastically improved patient outcomes. Still, these therapies can be improved to limit off-target effects, mitigate systemic toxicities, and increase overall efficacies. Nanoscale engineering offers strategies that enable researchers to attain these goals through the manipulation of immune cell functions, such as enhancing immunity against cancers and pathogens, controlling the site of immune response, and promoting tolerance via the delivery of small molecule drugs or biologics. By tuning the properties of the nanomaterials, such as size, shape, charge, and surface chemistry, different types of immune cells can be targeted and engineered, such as dendritic cells for immunization, or T cells for promoting adaptive immunity. Researchers have come to better understand the critical role the immune system plays in the progression of pathologies besides cancer, and developing nanoengineering approaches that seek to harness the potential of immune cell activities can lead to favorable outcomes for the treatment of injuries and diseases.